Abstract
Background—Intestinal metaplastic mucosa in Barrett's oesophagus can be replaced by squamous epithelium after mucosal thermal ablation associated with acid suppression therapy. Aims—To assess whether restoration of squamous epithelium can be obtained after ablation of Barrett's oesophagus using argon plasma coagulation (APC) associated with proton pump inhibitor (PPI) therapy. Methods—Thirty one patients with Barrett's oesophagus received APC. Omeprazole (40 mg/day) was given from the first APC application to one month after completion of the treatment, then given symptomatically. Twenty four hour pH-metry was performed during endotherapy. Results—Complete re-epithelialisation was visualised at endoscopy in 25/31 patients (81%) after a mean number of 2.4 APC sessions (range 1-4). Only partial squamous re-epithelialisation was observed in three patients and three others had no eradication. At histological assessment, eradication of Barrett's oesophagus was only confirmed in 19/31 patients (61%) due to the presence of a few residual Barrett's glands under the new squamous epithelium. Complete eradication was related to a Barrett's oesophagus segment length of less than 4 cm and the absence of circumferential extension but not to the normalisation of oesophageal acid exposure under PPI therapy. Seventeen patients with apparently complete endoscopic and histological eradication of Barrett's oesophagus were re-evaluated at one year; eight (47%) disclosed relapsing islands of Barrett metaplasia despite continuous omeprazole therapy (10-40 mg/day). Conclusions—APC combined with 40 mg omeprazole daily can eradicate Barrett's mucosa with apparent squamous re-epithelialisation in the majority of patients even in the absence of normalisation of oesophageal acid exposure. However, one year after endotherapy for Barrett's oesophagus, relapse is frequent but limited in extent.
Keywords: Barrett's oesophagus; argon plasma coagulation; omeprazole; gastro-oesophageal reflux; Barrett's adenocarcinoma
Full Text
The Full Text of this article is available as a PDF (141.2 KB).
Figure 1 .
Circumferential Barrett's mucosa before endotherapy.
Figure 2 .
Barrett's mucosa at the end of APC (first session).
Figure 3 .
Biopsy specimen sampled in an area of squamous appearing mucosa but showing persistence of a few remaining metaplastic glands under the new squamous epithelium.
Figure 4 .
Barrett's mucosa one year after complete re-epithelialisation showing persistence of squamous appearing mucosa. Arrowheads represent new squamocolumnar junction.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barham C. P., Jones R. L., Biddlestone L. R., Hardwick R. H., Shepherd N. A., Barr H. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut. 1997 Sep;41(3):281–284. doi: 10.1136/gut.41.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berenson M. M., Johnson T. D., Markowitz N. R., Buchi K. N., Samowitz W. S. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology. 1993 Jun;104(6):1686–1691. doi: 10.1016/0016-5085(93)90646-t. [DOI] [PubMed] [Google Scholar]
- Boch J. A., Shields H. M., Antonioli D. A., Zwas F., Sawhney R. A., Trier J. S. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology. 1997 Mar;112(3):760–765. doi: 10.1053/gast.1997.v112.pm9041237. [DOI] [PubMed] [Google Scholar]
- Brandt L. J., Kauvar D. R. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc. 1992 Sep-Oct;38(5):619–622. doi: 10.1016/s0016-5107(92)70536-7. [DOI] [PubMed] [Google Scholar]
- Chobanian S. J., Cattau E. L., Jr, Winters C., Jr, Johnson D. A., Van Ness M. M., Miremadi A., Horwitz S. L., Colcher H. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointest Endosc. 1987 Apr;33(2):99–101. doi: 10.1016/s0016-5107(87)71519-3. [DOI] [PubMed] [Google Scholar]
- Deviere J., Buset M., Dumonceau J. M., Rickaert F., Cremer M. Regression of Barrett's epithelium with omeprazole. N Engl J Med. 1989 Jun 1;320(22):1497–1498. doi: 10.1056/NEJM198906013202218. [DOI] [PubMed] [Google Scholar]
- Gore S., Healey C. J., Sutton R., Eyre-Brook I. A., Gear M. W., Shepherd N. A., Wilkinson S. P. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther. 1993 Dec;7(6):623–628. doi: 10.1111/j.1365-2036.1993.tb00143.x. [DOI] [PubMed] [Google Scholar]
- Grund K. E., Storek D., Farin G. Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. Endosc Surg Allied Technol. 1994 Feb;2(1):42–46. [PubMed] [Google Scholar]
- Johnson L. F., Demeester T. R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974 Oct;62(4):325–332. [PubMed] [Google Scholar]
- Laine L., Lewin D., Naritoku W., Estrada R., Cohen H. Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 1996 Nov;44(5):523–526. doi: 10.1016/s0016-5107(96)70002-0. [DOI] [PubMed] [Google Scholar]
- Laukka M. A., Wang K. K. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc. 1995 Jul;42(1):59–63. doi: 10.1016/s0016-5107(95)70245-8. [DOI] [PubMed] [Google Scholar]
- Levine D. S., Reid B. J. Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc. 1991 May-Jun;37(3):332–337. doi: 10.1016/s0016-5107(91)70726-8. [DOI] [PubMed] [Google Scholar]
- Malesci A., Savarino V., Zentilin P., Belicchi M., Mela G. S., Lapertosa G., Bocchia P., Ronchi G., Franceschi M. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc. 1996 Dec;44(6):700–705. doi: 10.1016/s0016-5107(96)70055-x. [DOI] [PubMed] [Google Scholar]
- McArdle J. E., Lewin K. J., Randall G., Weinstein W. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol. 1992 May;23(5):479–482. doi: 10.1016/0046-8177(92)90123-k. [DOI] [PubMed] [Google Scholar]
- Overholt B. F., Panjehpour M. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc. 1995 Jul;42(1):64–70. doi: 10.1016/s0016-5107(95)70246-6. [DOI] [PubMed] [Google Scholar]
- Pera M., Cameron A. J., Trastek V. F., Carpenter H. A., Zinsmeister A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993 Feb;104(2):510–513. doi: 10.1016/0016-5085(93)90420-h. [DOI] [PubMed] [Google Scholar]
- Spechler S. J. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann Intern Med. 1987 Jun;106(6):902–904. doi: 10.7326/0003-4819-106-6-902. [DOI] [PubMed] [Google Scholar]
- Spechler S. J., Goyal R. K. Barrett's esophagus. N Engl J Med. 1986 Aug 7;315(6):362–371. doi: 10.1056/NEJM198608073150605. [DOI] [PubMed] [Google Scholar]
- Spechler S. J., Robbins A. H., Rubins H. B., Vincent M. E., Heeren T., Doos W. G., Colton T., Schimmel E. M. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 1984 Oct;87(4):927–933. [PubMed] [Google Scholar]
- Wahab P. J., Mulder C. J., den Hartog G., Thies J. E. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy. 1997 Mar;29(3):176–181. doi: 10.1055/s-2007-1004159. [DOI] [PubMed] [Google Scholar]




